Galapagos, a global biotechnology company, has appointed the founding CEO of its new subsidiary & announced the search for a ...

Join Mike O’Mara, COO of Cellipont Bioservices, and Marcia Blackmoore, VP of Customer Operations at L7 Informatics, for a ...

Repertoire Immune Medicines has entered into a collaboration and license agreement with Genentech to discover and develop innovative T cell-targeted immune medicines.

Antag Therapeutics, a biopharmaceutical company pioneering novel treatments for obesity, has appointed three new hires to support the Company’s next phase of growth following the recent initiation of ...

Singh will lead the discovery and clinical translation of peptide medicines, investing in new technologies, including data and computational science.

Board Certified in Endocrinology, Diabetes, and Metabolism and Internal Medicine, Dr. Caveney leads IQVIA’s Obesity, ...

Carbogen Amcis’ Shanghai facility has successfully obtained its first Drug Manufacturing License (DML) from China’s NMPA.

The agreement is valued at over $3 billion and increases U.S. manufacturing capacity to help ensure patient access to ...

Scale-up is a common problem encountered in all forms of development across industries, and oral solid dose manufacturing ...

Key steps for pharmaceutical companies to meet FDA’s upcoming nitrosamine testing requirements and ensure product safety.

Andrei Georgescu of Vivodyne discusses key advantages of its humanized drug testing platform and the impact of the FDA’s policy shift.

How Ardena’s integrated services, nanomedicine expertise, and North American expansion are advancing drug development for ...